March 17, 2021
As many as 60% of food allergy sufferers may be over-diagnosed, leading to unnecessary food avoidance, increased patient anxiety, and annual costs of nearly $25 billion in the US alone.
One in four Americans avoid purchasing products containing the top 9 food allergens, and agricultural processors continue to adjust their food ingredient segregation infrastructure to align with consumer demands. However, best practices and product labeling remains voluntary and inconsistent.
Tune in to watch Jim Garner, CEO of AllerGenis, discuss how the company is working to change these dynamics, and to answer questions about the market opportunity.
Download the Presentation Learn More About AllerGenis
-
Jim GarnerCEO & Board Member, AllerGenis
Jim has over 30 years of experience providing products and services to help patients and doctors better diagnose and manage health conditions. Jim is the chief executive officer and board member of AllerGenis. He led the effort to establish the company in 2017 to develop precision, data-driven diagnostics to help healthcare providers, patients, and caregivers more accurately and safely diagnose, assess, and monitor patients with food allergies. Prior to joining AllerGenis, Jim held successive executive leadership roles with life science companies, including Integrated Diagnostics and UnitedHealth Group. Jim served as Captain in the United States Army where he was Air-Cavalry Troop Commander, among other roles and distinctions. Jim lives in Florida with his family where he enjoys surfing, golfing, and tennis with his wife and two sons.
Let GAI News inform your engagement in the agriculture sector.
GAI News provides crucial and timely news and insight to help you stay ahead of critical agricultural trends through free delivery of two weekly newsletters, Ag Investing Weekly and AgTech Intel.